Doprin | Suppliers | Impurities | Impurity Standards| PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Doprin
Others

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Aspen API. More than just an API™

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Doprin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

46 API Suppliers, 21 USDMF, 13 CEP/COS, 4 JDMF, 2 EU WC, 9 KDMF, 11 NDC API, 17 Listed Suppliers, $ API Reference Price

46 API Suppliers
21 USDMF
13 CEP/COS
4 JDMF
2 EU WC
9 KDMF
11 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

39 Drugs in Development

39 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

410 FDF Dossiers, 134 FDA Orange Book, 189 Europe, 30 Canada, 14 South Africa, 43 Listed Dossiers

410 FDF Dossiers
134 FDA Orange Book
189 Europe
30 Canada
14 South Africa
43 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG;100MG, TABLET;ORAL - 25MG;100MG, TABLET;ORAL - 25MG;250MG, TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG, CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG, CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG, CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG, TABLET;ORAL - 12.5MG;200MG;50MG, TABLET;ORAL - 18.75MG;200MG;75MG, TABLET;ORAL - 25MG;200MG;100MG, TABLET;ORAL - 31.25MG;200MG;125MG, TABLET;ORAL - 37.5MG;200MG;150MG, TABLET;ORAL - 50MG;200MG;200MG

TABLET;ORAL - 10MG;100MG
TABLET;ORAL - 25MG;100MG
TABLET;ORAL - 25MG;250MG
TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG
CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG
CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG
CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG
TABLET;ORAL - 12.5MG;200MG;50MG
TABLET;ORAL - 18.75MG;200MG;75MG
TABLET;ORAL - 25MG;200MG;100MG
TABLET;ORAL - 31.25MG;200MG;125MG
TABLET;ORAL - 37.5MG;200MG;150MG
TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 4 Evonik, 4 Rochem International Inc, 21 SPI Pharma, 8 DKSH, 7 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 29 BASF, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 12 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

88 Fillers, Diluents & Binders, 64 Coating Systems & Additives, 46 Disintegrants & Superdisintegrants, 38 Controlled & Modified Release, 36 Direct Compression, 34 Solubilizers, 34 Thickeners and Stabilizers, 31 Granulation, 26 Taste Masking, 23 Film Formers & Plasticizers, 21 Chewable & Orodispersible Aids, 21 Parenteral, 20 Lubricants & Glidants, 17 Co-Processed Excipients, 14 Topical, 10 Rheology Modifiers, 8 Emulsifying Agents, 8 API Stability Enhancers, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

88 Fillers, Diluents & Binders
64 Coating Systems & Additives
46 Disintegrants & Superdisintegrants
38 Controlled & Modified Release
36 Direct Compression
34 Solubilizers
34 Thickeners and Stabilizers
31 Granulation
26 Taste Masking
23 Film Formers & Plasticizers
21 Chewable & Orodispersible Aids
21 Parenteral
20 Lubricants & Glidants
17 Co-Processed Excipients
14 Topical
10 Rheology Modifiers
8 Emulsifying Agents
8 API Stability Enhancers
5 Coloring Agents
5 Empty Capsules
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 99 News #PharmaBuzz

3 Data Compilation #PharmaFlow
99 News #PharmaBuzz

GLOBAL SALES INFORMATION

176 Regulatory FDF Prices, 16 Annual Reports

176 Regulatory FDF Prices
16 Annual Reports

MARKET PLACE

24 APIs, 5 FDF Dossiers

24 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

154 US Patents, 4 US Exclusivities

154 US Patents
4 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 2 Others

1 EDQM
2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 86 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

2 All

01 1 Aozeal Certified Standards

02 1Piramal Pharma Solutions

filter CAS Number Reset all filters

2 All

01 1339186-39-9

02 176757-91-0

filter Details Reset all filters

2 All

01 1In stock

02 1Blank

filter Country Reset all filters

2 All

01 2U.S.A

Product Main Page

01

Aozeal Certified Standards

Excipient World

Not Confirmed

Aozeal Certified Standards

Excipient World

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Levodopa Impurity 3

CAS Number : 339186-39-9

Quantity Per Vial :

Sale Unit :

Price :

Details : In stock

Monograph :

Storage :

Code/Batch No : L0038.12

Product Web Link

Digital Content

02

Piramal Pharma Solutions

Excipient World

Not Confirmed

Piramal Pharma Solutions

Excipient World

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

(S)-2-((tert-Butoxycarbonyl)amino)-3-\n(4-eth...

CAS Number : 76757-91-0

Quantity Per Vial :

Sale Unit :

Price :

Details :

Monograph :

Storage :

Code/Batch No :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!